AU2001261424A1 - Lipid metabolism enzymes - Google Patents

Lipid metabolism enzymes

Info

Publication number
AU2001261424A1
AU2001261424A1 AU2001261424A AU6142401A AU2001261424A1 AU 2001261424 A1 AU2001261424 A1 AU 2001261424A1 AU 2001261424 A AU2001261424 A AU 2001261424A AU 6142401 A AU6142401 A AU 6142401A AU 2001261424 A1 AU2001261424 A1 AU 2001261424A1
Authority
AU
Australia
Prior art keywords
lipid metabolism
metabolism enzymes
enzymes
lipid
metabolism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261424A
Inventor
Janice Au-Young
Debopriya Das
Li Ding
Vicki S. Elliott
Ameena R. Gandhi
Liam Kearney
Farrah A. Khan
Preeti Lal
Yan Lu
Danniel B. Nguyen
Roopa Reddy
Michael Thornton
Catherine M. Tribouley
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001261424A1 publication Critical patent/AU2001261424A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001261424A 2000-05-11 2001-05-11 Lipid metabolism enzymes Abandoned AU2001261424A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US20351100P 2000-05-11 2000-05-11
US60/203,511 2000-05-11
US20790300P 2000-05-25 2000-05-25
US60/207,903 2000-05-25
US21015000P 2000-06-07 2000-06-07
US60/210,150 2000-06-07
US21339200P 2000-06-23 2000-06-23
US60/213,392 2000-06-23
PCT/US2001/015210 WO2001085956A2 (en) 2000-05-11 2001-05-11 Lipid metabolism enzymes

Publications (1)

Publication Number Publication Date
AU2001261424A1 true AU2001261424A1 (en) 2001-11-20

Family

ID=27498501

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261424A Abandoned AU2001261424A1 (en) 2000-05-11 2001-05-11 Lipid metabolism enzymes

Country Status (5)

Country Link
EP (1) EP1280918A2 (en)
JP (1) JP2004513611A (en)
AU (1) AU2001261424A1 (en)
CA (1) CA2407864A1 (en)
WO (1) WO2001085956A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001264753A1 (en) * 2000-05-19 2001-12-03 Millennium Pharmaceuticals, Inc. 46638, a putative family member of human lipoxygenase
US6812017B2 (en) 2000-10-11 2004-11-02 Centre National De La Recherche Scientique - Cnrs Mammalian secreted group IIF phospholipase A2
WO2002038773A2 (en) 2000-11-08 2002-05-16 Millennium Pharmaceuticals, Inc. A human phospholipase c and uses thereof
WO2003033689A1 (en) * 2001-10-12 2003-04-24 Centre National De La Recherche Scientifique -Cnrs- Cloning and recombinant expression of mammalian secreted group iif phopholipase a2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060302A (en) * 1993-09-24 2000-05-09 Shionogi & Co., Ltd. Human phospholipase C-α and DNA sequence encoding the same
AU2001252945A1 (en) * 2000-03-24 2001-10-08 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer

Also Published As

Publication number Publication date
JP2004513611A (en) 2004-05-13
CA2407864A1 (en) 2001-11-15
EP1280918A2 (en) 2003-02-05
WO2001085956A3 (en) 2002-09-19
WO2001085956A2 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
AU4211600A (en) Modified lipid production
AU2002216470A1 (en) Cholesterol lowering supplement
AU2001277969A1 (en) Direct internet advertising
AU2001288754A1 (en) Multiple advertising
AU2002357860A1 (en) Enzymes
AU1878601A (en) Enzyme
AU2001247049A1 (en) Autostereoscopic display
AU2001264055A1 (en) Display assembly
AU5101599A (en) Tetrahydrofolate metabolism enzymes
AU2001281636A1 (en) Advertising
AU2001227900A1 (en) Drug metabolizing enzymes
AU2001274981A1 (en) Drug metabolizing enzymes
AU5018900A (en) Lipid metabolism transcription factor
AU2001270303A1 (en) Drug metabolizing enzymes
AU2001231053A1 (en) Lipid metabolism enzymes
AU2002347778A1 (en) Enzymes
AU2001294245A1 (en) Compositions for improving lipid metabolism
AU2001245397A1 (en) Lipid metabolism enzymes
AU2001261424A1 (en) Lipid metabolism enzymes
AU2001273235A1 (en) Lipid metabolism molecules
AU2001255324A1 (en) Drug metabolizing enzymes
AU2001235000A1 (en) Drug metabolizing enzymes
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU2001257427A1 (en) Rna metabolism proteins
AU2001278154A1 (en) Drug metabolizing enzymes